A Prospective, Multicenter Study on the Clinical Effectiveness and Safety of Abiraterone Plus Prednisone in Metastatic Hormone-Sensitive Prostate Cancer in Korea: Real-World Data Analysis

Purpose This postmarketing surveillance (PMS) study aimed to evaluate real-world data on the effectiveness and safety of abiraterone acetate plus prednisone (AAP) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Materials and Methods This prospective, multicenter observational...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hyomyoung Lee, Seung-hwan Jeong, Sangeun Yeon, Youngdoe Kim, Jaeyoung Joung, Hanjong Ahn, Seongsoo Jeon, Hakmin Lee, Sangchul Lee, Choung-Soo Kim, Cheol Kwak
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Korean Urological Oncology Society 2025-07-01
Edice:	Journal of Urologic Oncology
Témata:	abiraterone acetate prostatic neoplasms prostate-specific antigen postmarketing surveillance
On-line přístup:	http://www.e-juo.org/upload/pdf/juo-255000360018.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!